Overview
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $916,564 | |
| Capital expenditure | $2,986,475 | |
| Foreign sales | 4.73% of revenue ($2,351,981) | |
| Revenue structure | wynajem środków trwałych | |
| Receivables write-downs | $113,680 | |
| Future lease and rent payments | $36,742,363 |
Filing timeliness
Financial statements were filed on time, on average 80 days early. All were audited by a statutory auditor.
- 202525/05/2026
- 202405/05/2025
- 202316/05/2024
- 202219/05/2023
- 202116/05/2022
- 202020/04/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Websites
The site is available in: Polish and English.
- pharmalink.plLogistyka leków i produktów leczniczych - PharmalinkWordPress 1.0LinkedIn AdsGoogle Tag ManagerYoast SEOApache
Public procurement
9 tenders recorded as contractor: 3 national ($306,967) and 6 EU ($6,983,626).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Sep 29, 2026 | Supply of radioisotope materials | $301.3K$301,291 | Mazowiecki Szpital Wojewódzki Im. Św. Jana Pawła II w Siedlcach sp. z o.o. | |
| Aug 20, 2026 | Purchase and delivery of the medicinal product Lutetium (177Lu) oxodotreotide, solution for infusion, for Klinika Endokrynologii Świętokrzyskiego Centrum Onkologii w Kielcach | $275.5K$275,527 | Świętokrzyskie Centrum Onkologii Samodzielny Publiczny Zakład Opieki Zdrowotnej w Kielcach | |
| Jul 7, 2026 | 91/PN/2026 - Successive supply of the radiopharmaceutical lutetium Lu-177 oxodotreotide (Lutathera) for UCK | $4.8M$4,784,441 | Uniwersyteckie Centrum Kliniczne |
The company is the contractor in 6 public sector contracts, worth USD 296.10k in total. They were signed with 4 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Aug 20, 2026 | Transport service for drug samples | $98.82 | Inspekcja Weterynaryjna Wojewódzki Inspektorat Weterynarii we Wrocławiu | |
| Aug 11, 2026 | Medicinal product Lutetium (177Lu) oxodotreotide, solution for infusion | $275,527 | Świętokrzyskie Centrum Onkologii Samodzielny Publiczny Zakład Opieki Zdrowotnej w Kielcach | |
| Aug 7, 2026 | Transport services | $19,449 | DOM Pomocy Społecznej Im. W.Łukasińskiego |
Trademarks
The company holds 1 active trademark registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2009.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| pharmalink | Z.473616 | 35, 39, 41 | Protected | Jul 3, 2027 | |
| pharmalink | Z.361979 | 39, 42 | Proceedings discontinued | – |
| Mark | Protected until | |
|---|---|---|
| pharmalink | Jul 3, 2027 | |
| pharmalink | – |
Job offers
The company has its own careers page: pharmalink.pl/kariera.
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the joint action of two members of the management board, or of a member of the management board jointly with a commercial proxy, is required for the validity of declarations made on behalf of the company.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 20,000 | $2,701,242.57 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Capital group
The company belongs to the Pelion (Poland) group, which is its direct owner. The group has 10 companies, 1 of them abroad.
| Name | Country |
|---|---|
| B2C Business Eight | |
| Daruma | |
| DOZ | |
| Pharmena | |
| Polska Grupa Farmaceutyczna |
Bank accounts
Registered as a VAT taxpayer on 1998-11-02.
22 1020 3352 0000 1302 0146 5988
86 1050 0086 1000 0090 8135 4384
81 1140 1108 0000 5870 5200 1003
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 2.1MPLN 2,114,325 |
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fortis Logistics Group sp. z o.o. | $79,270,560.41 | fortislogistics.pl | ||
| Trade Trans Combi sp. z o.o. | $50,069,985.05 | tradetrans.com.pl | ||
| Extrego sp. z o.o. | $32,111,242.99 | extrego.com | ||
| HART Logistics sp. k. | $27,585,496.70 | hartlogistics.pl | ||
| Woodeco Tsl sp. z o.o. | $27,087,393.27 | woodeco.eu | ||
| LEX Logistics sp. z o.o. | $24,888,333.50 | lexlogistics.pl | ||
| Robano sp. z o.o. | $18,761,166.30 | robano.pl | ||
| Envio Group Poland sp. z o.o. + limited partnership | $18,228,715.64 | enviogroup.pl | ||
| Liner J. Krywko sp. k. | $18,062,009.46 | liner24.com | ||
| Frontier Logistics sp. z o.o. | $15,973,767.65 | frontier-logistics.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-09-16 | Address change (Ul. Kinga C. Gillette 1, 94-406, Łódź → Ul. Św. Teresy Od Dzieciątka Jezus 105, 91-222, Łódź) | |
| 2017-04-19 | Address change (Zbąszyńska 3, 91-342, Łódź → Ul. Kinga C. Gillette 1, 94-406, Łódź) | |
| 2009-08-10 | Name change ("pharma Logistic" → "pharmalink") | |
| 2009-04-16 | Name change ("polska Grupa Farmaceutyczna-Łódź" → "pharma Logistic") | |
| 2008-11-12 | Name change (Polska Grupa Farmaceutyczna-Łódź Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji → "polska Grupa Farmaceutyczna-Łódź") |
FAQ
Last updated: 2026-10-07